HOME / CONTACT US
繁體版 / 简体版
 

Board of Directors

The company has seven to nine directors and adopts a candidate nomination system. The term of office is three years. The shareholders will elect from the list of candidates, and they may be re-elected. The company elected the seventh board of directors (7 directors, including 3 independent directors) at the general meeting of shareholders in June 2018, with a term of office from June 22, 2018 to June 21, 2021. In order to establish a good governance system for the board of directors of the company, improve supervision functions and strengthen management functions, the "Rules of Procedures for the Board of Directors of Public Offering Companies" have been formulated for compliance.
 
Directors Biographies:

Chairman
Huang, Shan-Ney
Current Position(s):
  • žChairman, Microbio Co., Ltd.
  • žChairman, Oneness Biotech Co., Ltd.
  • Chairman, Harmony Organic Agriculture Foundation
Experience:
  • žDirector, Agriculture and Food Agency, Council of Agriculture, Executive Yuan
  • Director, Tainan District Agricultural Research and Extension Station, Council of Agriculture, Executive Yuan
Education:
  • žPhD of Michigan State University
First Elected Date:
  • ž June 20, 2000
 
Director
Huang, Cheng Chun
Current Position(s):
  • Director, Microbio Co., Ltd.
  • žSupervisor, Hedonist Biochemical Technologies Co., Ltd.
Experience:  
  • Audit Manager, Chung-Ching Textile Co., Ltd.
  • Vice President of Administration Department, Wagon Group
Education:
  • žTamsui Institute of Business Administration
First Elected Date:
  • žJune 25, 2004
 
Director
Yang, Pan Chyr
žCurrent Position(s):
  • Director, Microbio Co., Ltd.
  • Dean, College of Medicine, National Taiwan University
  • Professor, Department of Internal Medicine, College of Medicine, National Taiwan University
  • Program Director, Microarray Core Facility, National Research Program for Genomic Medicine
Experience:
  • President, National Taiwan University
  • Director, NTUH National Clinical Trial and Research Center
  • President, Taiwan Society of Pulmonary and Critical Care Medicine
Education:
  • M.D., College of Medicine, National Taiwan University
  • Ph.D., Graduate Institute of Clinical Medicine, National Taiwan University
First Elected Date:
  • On July 7, 2020, the company's corporate director was re-appointed as director Yang as the representative
 
Independent Director
Lai, Yuan Ho
Current Position(s):
  • Independent Director, Microbio Co., Ltd.
  • Director, Chilisin Electronics Corp.
  • Supervisor, Kaimei Electronics Corp.
  • Supervisor, Global Testing Corp.
  • Honorary Professor, College of Law, National Chengchi University
Experience:
  • Dean, College of Law, National Chengchi University Director,
  • Chairman, Chilisin Electronics Corp.
  • Chairman, Teapo Electronic Corporation
  • Consultant, Fair Trade Commission, Executive Yuan
Education:
  • Bachelor of Laws, National Taiwan University
  • Ph.D., College of Law, Kobe University
First Elected Date:
  • ž June 6, 2003
 
Independent Director
Tsai, Kao Chung
Current Position(s):
  • žIndependent Director, Microbio Co., Ltd.
  • žChairman, Champion Microelectronic Corp.
  • žDirector, Glyconex Inc.
  • žIndependent Director, Holy Stone Healthcare Co., Ltd.
Experience:
  • žVice president of Underwriting Department, Barits Securities Corporation
  • Manager of Underwriting Department, Taiwan International Securities Co.,LTD.
Education:
  • žMaster of Department of Economics, Soochow University
First Elected Date:
  • žMay 29, 2006
 
Independent Director
Han, Li Chun
Current Position(s):
  • žIndependent Director, Microbio Co., Ltd.
  • Independent Director, StemCyte International Ltd.
  • Chairman, President Futures Co., Ltd.
Experience:
  • ž Vice president of Brokerage Business, President Securities Corp
  • Director, President Futures Co., Ltd.
  • Supervisor, President Futures Co., Ltd.
Education:
  • žDepartment of Economics, National Chung Hsing University
First Elected Date:
  • žJune 6, 2012
(note):Director Chun Hong Chen was resigned due to busy business on December 16, 2020.
 
 
The implementation of diversity by board members

The company stipulates in the "Code of Practice on Corporate Governance" that the composition of the board of directors should be diversified. Except for directors who are also managers of the company, it is not advisable to exceed one-third of the number of directors, and it should formulate appropriate diversification policies based on its own operation, operation type and development needs.
 
Among the current 7 board members of the company (including 3 independent directors), only the chairman, Shan-Ney Huang, is also the manager of the company. In other words, the proportion of directors with employee status is only 14%, which does not exceed one third of the board of directors.
 
It is mentioned in the Company's "Code of Practice on Corporate Governance" that board members should generally possess the knowledge, skills and literacy necessary to perform their duties. In order to achieve the ideal goal of corporate governance, the overall board of directors should have the following capabilities:
 
1. Operational judgment ability.
2. Accounting and financial analysis capabilities.
3. Operation and management capabilities.
4. Crisis management capabilities.
5. Industry knowledge.
6. International market outlook.
7. Leadership.
8. Decision-making ability.
 
Chairman Shan-Ney Huang used to be the Director of the Agriculture and Food Agency of the Council of Agriculture of the Executive Yuan. He is currently the Chairman of the Oneness Biotech Co., Ltd. He has operational judgment, management, crisis management, industrial knowledge and leadership and decision-making capabilities.
 
Director Yuan Ho Lai served as the Dean of the Law School of National Chengchi University, a minister of the Examination Yuan of ROC, and the chairman of the listed company Chilisin Electronics Co., He has operational judgment, management, crisis management, industry knowledge, international market outlook and leadership and decision-making ability.
 
Director Kao Chung Tsai used to be a senior manager of a securities financial company and is currently the chairman of a listed company Champion Microelectronic Corp. He has operational judgment, accounting and financial analysis, management, crisis management, industry knowledge, international market outlook and leadership and decision-making ability.
 
Director Li Chun Han is the current chairman of the securities finance company, with operational judgment, accounting and financial analysis, operation management, crisis management, industry knowledge, international market outlook and leadership and decision-making capabilities.
 
Director Cheng Chun Huang is currently the supervisor of Hedonist Biochemical Technologies Co., Ltd., with operational judgment and industrial knowledge capabilities.
 
Director Pan Chyr Yang served as a professor at National Taiwan University and an associate professor of internal medicine at the College of Medicine of National Taiwan University. He is currently the dean of the College of Medicine of the National Taiwan University and the program director of the Microarray Core Facility of National Research Program for Genomic Medicine. He has operational management, crisis management, industry knowledge and leadership and Decision-making capacity.
 
In summary, the overall capabilities of the company's board of directors have complied with the diversification policy stipulated in the Code.
 
 
Results of the most recent annual board performance evaluation

The company formulated the "Self-Evaluation or Peer Evaluation of the Board of Directors" on August 11, 2015, and conducted regular board performance evaluation tasks in accordance with the regulations rigorously. The performance evaluation of the board of directors in 2019 has been completed. The Compensation committee had evaluated according to the indicators listed in the method, and the evaluation results will report to the 4th board of directors meeting of 2020 (held on May 11, 2020) and the 1st Compensation committee meeting of 2020 (held on of August 11, 2020).
 
The measurement items of the performance evaluation of the company's board of directors include the following five aspects:
1.      Participation in the operation of the company;
2.      Improvement of the quality of the board of directors' decision making;
3.      Composition and structure of the board of directors;
4.      Election and continuing education of the directors; and
5.      Internal control.
 
The year 2019 board performance evaluation result was 96 marks. According to the evaluation results, the overall operation of the board of directors is still good.
 
The company revised the "Self-Evaluation or Peer Evaluation of the Board of Directors" on November 13, 2020, which clearly stipulates that the Company's board performance evaluation shall be conducted by an external independent professional institution or a panel of external experts and scholars at least once every three years.. In 2020, the "Taiwan Institute of Ethical Business and Forensics" was appointed to perform the performance evaluation of the board of directors. For details, please refer to the following link:
 
2020 Annual Board Performance External Evaluation PDF

In addition, the company has disclosed the "Self-Evaluation or Peer Evaluation of the Board of Directors" on the company website for inquiries.